NeuroOne Medical Tech Analyst Ratings
NeuroOne Medical Tech Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/15/2023 | 105.61% | Alliance Global Partners | $3.25 → $2.2 | Maintains | Buy |
03/28/2022 | — | Craig-Hallum | Downgrades | Buy → Hold | |
12/03/2021 | 437.38% | Alliance Global Partners | → $5.75 | Initiates Coverage On | → Buy |
11/15/2021 | 460.75% | Craig-Hallum | → $6 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
2023年08月15日 | 105.61% | 联盟全球合作伙伴 | $3.25→$2.2 | 维护 | 买 |
03/28/2022 | - | 克雷格-哈勒姆 | 评级下调 | 购买→Hold | |
12/03/2021 | 437.38% | 联盟全球合作伙伴 | →$5.75 | 开始承保 | →购买 |
2021年11月15日 | 460.75% | 克雷格-哈勒姆 | →$6 | 开始承保 | →购买 |
What is the target price for NeuroOne Medical Tech (NMTC)?
NeuroOne Medical Tech(NMTC)的目标价格是多少?
The latest price target for NeuroOne Medical Tech (NASDAQ: NMTC) was reported by Alliance Global Partners on August 15, 2023. The analyst firm set a price target for $2.20 expecting NMTC to rise to within 12 months (a possible 105.61% upside). 1 analyst firms have reported ratings in the last year.
联盟全球合作伙伴于2023年8月15日报道了NeuroOne Medical Tech(纳斯达克:nmtc)的最新目标价。这家分析公司将目标价定为2.2美元,预计NMTC将在12个月内上涨至(可能上涨105.61%)。1家分析公司在过去一年公布了评级。
What is the most recent analyst rating for NeuroOne Medical Tech (NMTC)?
NeuroOne Medical Tech(NMTC)的最新分析师评级是多少?
The latest analyst rating for NeuroOne Medical Tech (NASDAQ: NMTC) was provided by Alliance Global Partners, and NeuroOne Medical Tech maintained their buy rating.
分析师对NeuroOne Medical Tech(纳斯达克代码:NMTC)的最新评级由Alliance Global Partners提供,NeuroOne Medical Tech维持买入评级。
When is the next analyst rating going to be posted or updated for NeuroOne Medical Tech (NMTC)?
NeuroOne Medical Tech(NMTC)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeuroOne Medical Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeuroOne Medical Tech was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与NeuroOne Medical Tech的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。NeuroOne Medical Tech的上一次评级是在2023年8月15日提交的,所以你应该预计下一次评级将在2024年8月15日左右提供。
Is the Analyst Rating NeuroOne Medical Tech (NMTC) correct?
分析师对NeuroOne Medical Tech(NMTC)的评级正确吗?
While ratings are subjective and will change, the latest NeuroOne Medical Tech (NMTC) rating was a maintained with a price target of $3.25 to $2.20. The current price NeuroOne Medical Tech (NMTC) is trading at is $1.07, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的NeuroOne Medical Tech(NMTC)评级保持不变,目标价在3.25美元至2.20美元之间。NeuroOne Medical Tech(NMTC)目前的交易价格为1.07美元,超出了分析师的预测区间。